{"title":"San Antonio Breast Cancer Symposium 2021 - 44th Annual Meeting. Virtual/San Antonio - December 7-10, 2021","authors":"P. Sudha","doi":"10.1358/dof.2022.47.4.3421335","DOIUrl":null,"url":null,"abstract":"The 2021 San Antonio Breast Cancer Symposium was run as a hybrid meeting allowing its attendees to participate both in person at the Henry B. Gonzalez Convention Center, San Antonio, Texas, and virtually, taking into consideration the safety of attendees due to the ongoing COVID-19 pandemic. The symposium provided state-of-the-art information on etiology, experimental biology, diagnosis, prevention and treatment of breast cancer, as well as premalignant breast diseases.","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drugs of The Future","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1358/dof.2022.47.4.3421335","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
The 2021 San Antonio Breast Cancer Symposium was run as a hybrid meeting allowing its attendees to participate both in person at the Henry B. Gonzalez Convention Center, San Antonio, Texas, and virtually, taking into consideration the safety of attendees due to the ongoing COVID-19 pandemic. The symposium provided state-of-the-art information on etiology, experimental biology, diagnosis, prevention and treatment of breast cancer, as well as premalignant breast diseases.
期刊介绍：
A leading international, peer-reviewed biomedical research journal publishing articles on topics emerging from the confluence of fields including chemistry, biology, pharmacology, genomics and medicine, and addressed to scientists and researchers involved in drug design, discovery and development, target identification and validation, and the preclinical and clinical development of treatments for common as well as rare and neglected diseases and conditions.
The journal publishes monographs containing comprehensive product information on new compounds in development, including synthesis, preclinical pharmacology, pharmacokinetics and metabolism, safety, clinical studies and drug interactions, as well as review articles on a variety of topics, congress and meeting reports.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
